date,title,source
Oct-19-18,Innovate Biopharmaceuticals adds $5.2M to its coffers,American City Business Journals
Oct-29-18,Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study,GlobeNewswire
Oct-31-18,Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-05-18,"Innovate Biopharmaceuticals Announces Presentation at the BIO-Europe Conference, Copenhagen 2018 - 24th Annual Partnering Conference",GlobeNewswire
Nov-12-18,Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary Leaky Gut Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study,GlobeNewswire
Nov-13-18,Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights,GlobeNewswire
Nov-26-18,"Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P.",GlobeNewswire
Dec-04-18,"Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018",GlobeNewswire
Dec-11-18,Today's Research Reports on Trending Tickers: Teva Pharmaceutical and Innovate Biopharmaceuticals,ACCESSWIRE
Dec-14-18,Healthcare Stocks That Could Weather the Market Volatility,ACCESSWIRE
